Literature DB >> 17088330

Clinical and serological study of myasthenia gravis in HuBei Province, China.

Xiaofan Zhang1, Mingshan Yang, Jinzhi Xu, Min Zhang, Bethan Lang, Wei Wang, Angela Vincent.   

Abstract

BACKGROUND: Ocular and childhood myasthenia gravis (MG) cases seem relatively more common in Oriental than in Caucasian populations, but there have been no comprehensive serological studies on patients from mainland China.
METHODS: 391 unselected patients with MG attending Tongji Hospital in WuHan (the largest hospital in the province of HuBei, China) were studied during a 15-month period; most had already received treatment for their condition.
RESULTS: The male to female ratio was 0.8. 50% of the patients were children (<15 years), and age at onset showed a single peak at between 5 and 10 years of age. 64% of the children and 66% of the adults were positive for acetylcholine receptor (AChR) antibodies but the antibody titres were lower than in similar Caucasian studies, although this was partly due to the high incidence of ocular MG. Of the 43 patients with generalised MG without AChR antibodies, only 1 had muscle-specific kinase antibodies (2.5%) and 2 had voltage-gated calcium channel antibodies indicating probable Lambert-Eaton myasthenic syndrome. 75% of the children, compared with only 28% of the adults, had ocular MG. Thymoma was evident by MRI in 1.5% of children and in 20% of adults. Despite most patients having received prednisone, very few had obtained full clinical remission.
CONCLUSION: This study emphasises the frequency of early childhood onset with ocular symptoms and shows that many of these patients have AChR antibodies. By contrast, patients presenting in later age seem to be very uncommon in comparison with recent studies in Caucasian populations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17088330      PMCID: PMC2077769          DOI: 10.1136/jnnp.2006.100545

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  23 in total

1.  Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.

Authors:  W Hoch; J McConville; S Helms; J Newsom-Davis; A Melms; A Vincent
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

2.  Myasthenia gravis (MG): epidemiological data and prognostic factors.

Authors:  Renato Mantegazza; Fulvio Baggi; Carlo Antozzi; Paolo Confalonieri; Lucia Morandi; Pia Bernasconi; Francesca Andreetta; Ornella Simoncini; Angela Campanella; Ettore Beghi; Ferdinando Cornelio
Journal:  Ann N Y Acad Sci       Date:  2003-09       Impact factor: 5.691

3.  Prevalence of neuromuscular diseases in Chinese children: a study in southern China.

Authors:  Brian Chung; Virginia Wong; Patrick Ip
Journal:  J Child Neurol       Date:  2003-03       Impact factor: 1.987

Review 4.  Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.

Authors:  Angela Vincent; John Bowen; John Newsom-Davis; John McConville
Journal:  Lancet Neurol       Date:  2003-02       Impact factor: 44.182

5.  A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan.

Authors:  Noriaki Shinomiya; Yoshiko Nomura; Masaya Segawa
Journal:  Clin Immunol       Date:  2004-02       Impact factor: 3.969

6.  Evidence of underdiagnosis of myasthenia gravis in older people.

Authors:  A Vincent; L Clover; C Buckley; J Grimley Evans; P M Rothwell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

7.  Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.

Authors:  Amelia Evoli; Pietro A Tonali; Luca Padua; Mauro Lo Monaco; Flavia Scuderi; Anna P Batocchi; Mariapaola Marino; Emanuela Bartoccioni
Journal:  Brain       Date:  2003-06-23       Impact factor: 13.501

8.  Clinical aspects of MuSK antibody positive seronegative MG.

Authors:  D B Sanders; K El-Salem; J M Massey; J McConville; A Vincent
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

9.  Anti-p110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement.

Authors:  Flavia Scuderi; Mariapaola Marino; Lucrezia Colonna; Francesca Mannella; Amelia Evoli; Carlo Provenzano; Emanuela Bartoccioni
Journal:  Lab Invest       Date:  2002-09       Impact factor: 5.662

10.  Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.

Authors:  John McConville; Maria Elena Farrugia; David Beeson; Uday Kishore; Richard Metcalfe; John Newsom-Davis; Angela Vincent
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

View more
  30 in total

1.  Nationwide population-based epidemiological study of myasthenia gravis in taiwan.

Authors:  Chien-Hsu Lai; Hung-Fu Tseng
Journal:  Neuroepidemiology       Date:  2010-06-03       Impact factor: 3.282

2.  Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.

Authors:  Maria I Leite; Margaret Jones; Philipp Ströbel; Alexander Marx; Ralf Gold; Erik Niks; Jan J G M Verschuuren; Sonia Berrih-Aknin; Francesco Scaravilli; Aurea Canelhas; B Paul Morgan; Angela Vincent; Nick Willcox
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

3.  Seroprevalence of Mycoplasma suis infection in pigs in eastern China as estimated by a blocking enzyme-linked immunosorbent assay.

Authors:  Liang Zhongyang; Zhang Jiansong; Shen Yijuan; Xia Yuting; Li Yufeng; Xu Jiarong
Journal:  Can J Vet Res       Date:  2017-10       Impact factor: 1.310

4.  Characteristics of late-onset myasthenia gravis.

Authors:  Saša A Zivković; Paula R Clemens; David Lacomis
Journal:  J Neurol       Date:  2012-04-05       Impact factor: 4.849

5.  Long-term outcome of 424 childhood-onset myasthenia gravis patients.

Authors:  Mengcui Gui; Xuan Luo; Jing Lin; Yue Li; Min Zhang; Xiaofan Zhang; Mingshan Yang; Wei Wang; Bitao Bu
Journal:  J Neurol       Date:  2015-01-15       Impact factor: 4.849

6.  Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms.

Authors:  Yu Hong; Geir Olve Skeie; Paraskevi Zisimopoulou; Katerina Karagiorgou; Socrates J Tzartos; Xiang Gao; Yao-Xian Yue; Fredrik Romi; Xu Zhang; Hai-Feng Li; Nils Erik Gilhus
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

7.  The high frequency and clinical feature of seronegative myasthenia gravis in Southern China.

Authors:  Hui-Yu Feng; Hai-Yan Wang; Wei-Bin Liu; Xue-Tao He; Xin Huang; Chuan-Ming Luo; Yan Li
Journal:  Neurol Sci       Date:  2012-07-25       Impact factor: 3.307

8.  A cohort study on myasthenia gravis patients in China.

Authors:  Wei Wang; Yu-Ping Chen; Zhong-Kui Wang; Dong-Ning Wei; Ling Yin
Journal:  Neurol Sci       Date:  2013-02-20       Impact factor: 3.307

Review 9.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

10.  Expression of immune molecules CD25 and CXCL13 correlated with clinical severity of myasthenia gravis.

Authors:  Min Zhang; Jun Guo; Hongzeng Li; Yongan Zhou; Feng Tian; Li Gong; Xianni Wang; Zhuyi Li; Wei Zhang
Journal:  J Mol Neurosci       Date:  2013-02-10       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.